ATP-binding cassette transporter inhibitor potency and substrate drug affinity are critical determinants of successful drug delivery enhancement to the brainAristeidis Lentzas, Olaf van Tellingen, Jos H. Beijnen et al.|Fluids and Barriers of the CNS|2024Cited by 9
P10.21.A THE ABCB1/ABCG2 INHIBITOR ELACRIDAR IS A MORE POTENT PHARMACOENHANCER COMPARED TO TARIQUIDAR FOR TREATMENT OF INTRACRANIAL TUMORS WITH SMALL MOLECULE DRUGSAristeidis Lentzas, Olaf van Tellingen, Mark C. de Gooijer et al.|Neuro-Oncology|2023Cited by 1
Development and Validation of a Rapid and Simple LC‐MS/MS Method for Quantification of the Anti‐Microtubule, Anti‐Cancer Agent ABT‐751 in Human and Mouse Plasma and Mouse TissuesAristeidis Lentzas, Olaf van Tellingen, Mark C. de Gooijer et al.|Biomedical Chromatography|2025Cited by 0